Switzerland - Itali - Swissmedic (Swiss Agency for Therapeutic Products)

merck (schweiz) ag - interferonum beta-1a adnr - soluzione iniettabile in siringhe preriempite - interferonum beta-1a adnr 22 µg corresp. 6 mio u.i., alcohol benzylicus 2.5 mg, mannitolum, methioninum, poloxamerum 188, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium max. 0.03 mg. - multiple sklerose - biotechnologika

Switzerland - Itali - Swissmedic (Swiss Agency for Therapeutic Products)

merck (schweiz) ag - interferonum beta-1a adnr - soluzione iniettabile in siringhe preriempite - interferonum beta-1a adnr 44 µg corresp. 12 mio u.i., alcohol benzylicus 2.5 mg, mannitolum, methioninum, poloxamerum 188, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium max. 0.04 mg. - multiple sklerose - biotechnologika

Switzerland - Itali - Swissmedic (Swiss Agency for Therapeutic Products)

biogen switzerland ag - interferonum beta-1a adnr - soluzione iniettabile in siringa preriempita - interferonum beta-1a adnr 30 µg corresp. 6 mio u.i., natrii acetas trihydricus corresp. natrium 0.13 mg, acidum aceticum glaciale, arginini hydrochloridum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml. - multiple sklerose - biotechnologika

Switzerland - Itali - Swissmedic (Swiss Agency for Therapeutic Products)

merck (schweiz) ag - interferonum beta-1a adnr - soluzione iniettabile in cartucce - interferonum beta-1a adnr 66 µg corresp. 18 mio u.i., alcohol benzylicus 7.5 mg, mannitolum, methioninum, poloxamerum 188, natrii acetas trihydricus, acidum aceticum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 1.5 ml corresp. natrium max. 0.04 mg. - multiple sklerose - biotechnologika

Switzerland - Itali - Swissmedic (Swiss Agency for Therapeutic Products)

merck (schweiz) ag - interferonum beta-1a adnr - soluzione iniettabile in cartucce - interferonum beta-1a adnr 132 µg corresp. 36 mio u.i., alcohol benzylicus 7.5 mg, mannitolum, methioninum, poloxamerum 188, natrii acetas trihydricus, acidum aceticum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 1.5 ml corresp. natrium max. 0.06 mg. - multiple sklerose - biotechnologika

Switzerland - Itali - Swissmedic (Swiss Agency for Therapeutic Products)

merck (schweiz) ag - interferonum beta-1a adnr - soluzione iniettabile in penna preriempita - i) 8.8 mcg/0.2 ml: interferonum beta-1a adnr 8.8 µg corresp. 2.4 mio u.i., alcohol benzylicus 1.0 mg, mannitolum, methioninum, poloxamerum 188, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.2 ml corresp. natrium 0.01 mg. ii) 22 mcg / 0.5 ml: interferonum beta-1a adnr 22 µg corresp. 6 mio u.i., alcohol benzylicus 2.5 mg, mannitolum, methioninum, poloxamerum 188, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium max. 0.03 mg. - multiple sklerose - biotechnologika

Switzerland - Itali - Swissmedic (Swiss Agency for Therapeutic Products)

merck (schweiz) ag - interferonum beta-1a adnr - soluzione iniettabile in penna preriempita - interferonum beta-1a adnr 22 µg corresp. 6 mio u.i., alcohol benzylicus 2.5 mg, mannitolum, methioninum, poloxamerum 188, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium max. 0.03 mg. - multiple sklerose - biotechnologika

Switzerland - Itali - Swissmedic (Swiss Agency for Therapeutic Products)

merck (schweiz) ag - interferonum beta-1a adnr - soluzione iniettabile in penna preriempita - interferonum beta-1a adnr 44 µg corresp. 12 mio u.i., alcohol benzylicus 2.5 mg, mannitolum, methioninum, poloxamerum 188, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium max. 0.04 mg. - multiple sklerose - biotechnologika

Switzerland - Itali - Swissmedic (Swiss Agency for Therapeutic Products)

biogen switzerland ag - interferonum beta-1a adnr - soluzione iniettabile in penna pre-riempita - interferonum beta-1a adnr 30 µg corresp. 6 mio u.i., natrii acetas trihydricus corresp. natrium 0.13 mg, acidum aceticum glaciale, arginini hydrochloridum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml. - multiple sklerose - biotechnologika

Switzerland - Itali - Swissmedic (Swiss Agency for Therapeutic Products)

biogen switzerland ag - peginterferonum beta-1a - 63 mcg/0,5 ml - peginterferonum beta-1a 63 µg l-arginini hydrochloridum, natrii acetas trihydricus, acido aceticum glaciale, polysorbatum 20, acqua iniectabilia q.s. per una soluzione invece di 0,5 ml. - multiple sklerose - biotechnologika